Prevention and detection of disease
Results
All (8)
All (8) ((8 results))
- Articles and reports: 82-003-X202101100002Description:
There are important information gaps concerning the prevalence and distribution of infection control practices within workplaces continuing to operate during the COVID-19 pandemic.
Release date: 2021-11-17 - Articles and reports: 82-003-X202100600002Description:
This study aims to measure cancer incidence and mortality rates of Registered First Nations people in Ontario and to look at trends over time, particularly in cancer rates that are targeted by screening programs (cervical, breast, colorectal) or public health interventions (smoking). The federal Indian Register, the Ontario Cancer Registry and the Registered Persons Database were linked to develop a cohort of First Nations people diagnosed with cancer in Ontario.
Release date: 2021-06-16 - Articles and reports: 82-003-X201500514169Description:
The Cancer Risk Management Model incorporates the risk of developing cancer, disease screening and clinical management with cost and labour data to assess health outcomes and economic impact. A screening module added to the lung cancer module enables a variety of scenarios to be evaluated for different target populations with varying rates of participation, compliance, and frequency of low-dose computed tomography screening.
Release date: 2015-05-20 - Articles and reports: 82-003-X201000211153Geography: Province or territoryDescription:
This article describes specific aspects of the human papillomavirus surveillance and evaluation system that is being implemented in Manitoba.
Release date: 2010-05-19 - 5. An update on mammography use in Canada ArchivedArticles and reports: 82-003-X200900310873Geography: CanadaDescription:
This article updates mammography use by Canadian women aged 50 to 69, and reports trends from 1990 to 2008 among the provinces.
Release date: 2009-06-30 - 6. Colorectal cancer testing in Canada 2008 ArchivedArticles and reports: 82-003-X200900310874Geography: CanadaDescription:
This article provides estimates of the reported level of colorectal cancer testing in the Canadian population aged 50 or older in 2008.
Release date: 2009-06-30 - Articles and reports: 11-522-X20020016722Geography: CanadaDescription:
Colorectal cancer (CRC) is the second cause of cancer deaths in Canada. Randomized controlled trials (RCT) have shown the efficacy of screening using faecal occult blood tests (FOBT). A comprehensive evaluation of the costs and consequences of CRC screening for the Canadian population is required before implementing such a program. This paper evaluates whether or not the CRC screening is cost-effective. The results of these simulations will be provided to the Canadian National Committee on Colorectal Cancer Screening to help formulate national policy recommendations for CRC screening.
Statistics Canada's Population Health Microsimulation Model was updated to incorporate a comprehensive CRC screening module based on Canadian data and RCT efficacy results. The module incorporated sensitivity and specificity of FOBT and colonoscopy, participation rates, incidence, staging, diagnostic and therapeutic options, disease progression, mortality and direct health care costs for different screening scenarios. Reproducing the mortality reduction observed in the Funen screening trial validated the model.
Release date: 2004-09-13 - Articles and reports: 82-003-X20020036557Geography: CanadaDescription:
After rising in the early 1990s, prostate cancer incidence rates have fallen. Mortality rates from the disease decreased among men aged 60 or older, but are little changed among younger men. In 2000/01, about four in 10 men aged 40 or older reported having had a prostate-specific antigen (PSA) test.
Release date: 2003-05-23
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (8)
Analysis (8) ((8 results))
- Articles and reports: 82-003-X202101100002Description:
There are important information gaps concerning the prevalence and distribution of infection control practices within workplaces continuing to operate during the COVID-19 pandemic.
Release date: 2021-11-17 - Articles and reports: 82-003-X202100600002Description:
This study aims to measure cancer incidence and mortality rates of Registered First Nations people in Ontario and to look at trends over time, particularly in cancer rates that are targeted by screening programs (cervical, breast, colorectal) or public health interventions (smoking). The federal Indian Register, the Ontario Cancer Registry and the Registered Persons Database were linked to develop a cohort of First Nations people diagnosed with cancer in Ontario.
Release date: 2021-06-16 - Articles and reports: 82-003-X201500514169Description:
The Cancer Risk Management Model incorporates the risk of developing cancer, disease screening and clinical management with cost and labour data to assess health outcomes and economic impact. A screening module added to the lung cancer module enables a variety of scenarios to be evaluated for different target populations with varying rates of participation, compliance, and frequency of low-dose computed tomography screening.
Release date: 2015-05-20 - Articles and reports: 82-003-X201000211153Geography: Province or territoryDescription:
This article describes specific aspects of the human papillomavirus surveillance and evaluation system that is being implemented in Manitoba.
Release date: 2010-05-19 - 5. An update on mammography use in Canada ArchivedArticles and reports: 82-003-X200900310873Geography: CanadaDescription:
This article updates mammography use by Canadian women aged 50 to 69, and reports trends from 1990 to 2008 among the provinces.
Release date: 2009-06-30 - 6. Colorectal cancer testing in Canada 2008 ArchivedArticles and reports: 82-003-X200900310874Geography: CanadaDescription:
This article provides estimates of the reported level of colorectal cancer testing in the Canadian population aged 50 or older in 2008.
Release date: 2009-06-30 - Articles and reports: 11-522-X20020016722Geography: CanadaDescription:
Colorectal cancer (CRC) is the second cause of cancer deaths in Canada. Randomized controlled trials (RCT) have shown the efficacy of screening using faecal occult blood tests (FOBT). A comprehensive evaluation of the costs and consequences of CRC screening for the Canadian population is required before implementing such a program. This paper evaluates whether or not the CRC screening is cost-effective. The results of these simulations will be provided to the Canadian National Committee on Colorectal Cancer Screening to help formulate national policy recommendations for CRC screening.
Statistics Canada's Population Health Microsimulation Model was updated to incorporate a comprehensive CRC screening module based on Canadian data and RCT efficacy results. The module incorporated sensitivity and specificity of FOBT and colonoscopy, participation rates, incidence, staging, diagnostic and therapeutic options, disease progression, mortality and direct health care costs for different screening scenarios. Reproducing the mortality reduction observed in the Funen screening trial validated the model.
Release date: 2004-09-13 - Articles and reports: 82-003-X20020036557Geography: CanadaDescription:
After rising in the early 1990s, prostate cancer incidence rates have fallen. Mortality rates from the disease decreased among men aged 60 or older, but are little changed among younger men. In 2000/01, about four in 10 men aged 40 or older reported having had a prostate-specific antigen (PSA) test.
Release date: 2003-05-23
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: